tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BLUE is currently covered by 7 analysts with an average price target of $-53.88. This is a potential upside of $-57.17 (-1737.69%) from yesterday's end of day stock price of $3.29.
Bluebird bio's activity chart (see below) currently has 7 price targets and 49 ratings on display. The stock rating distribution of BLUE is 47.06% BUY, 11.76% SELL and 41.18% HOLD.
Analysts average stock forecasts to be materialized ratio is 60.07% with an average time for these price targets to be met of 284.29 days.
Highest price target for BLUE is $8, Lowest price target is $3, average price target is $6.43.
Most recent stock forecast was given by GENA WANG from BARCLAYS on 31-Mar-2025.
Currently out of the existing stock ratings of BLUE, 8 are a BUY (47.06%), 2 are a SELL (11.76%), 7 are a HOLD (41.18%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
$4.5 (128.57%)
$40
1 months 12 days ago
(31-Mar-2025)
1/4 (25%)
$3.12 (63.93%)
195
Hold
$5
$1.5 (42.86%)
$2
2 months 19 days ago
(23-Feb-2025)
1/2 (50%)
$0.92 (22.55%)
36
Hold
$8
$4.5 (128.57%)
$4
4 months 6 days ago
(06-Jan-2025)
5/5 (100%)
$-1.02 (-11.31%)
134
Buy
$6
4 months 27 days ago
(15-Dec-2024)
1/1 (100%)
$-8.11 (-57.48%)
98
Hold
$3
$-0.5 (-14.29%)
$3
5 months 28 days ago
(14-Nov-2024)
0/3 (0%)
$-3.42 (-53.27%)
What is BLUE (Bluebird bio) average time for price targets to be met?
Which analyst has the current highest performing score on BLUE (Bluebird bio) with a proven track record?
Which analyst has the most public recommendations on BLUE (Bluebird bio)?
Which analyst is the currently most bullish on BLUE (Bluebird bio)?
Which analyst is the currently most reserved on BLUE (Bluebird bio)?
